AI-driven R&D GP has secured Small Business Innovative Research grants from NSF and USDA to pursue an AI-enabled research program, indicating potential collaboration opportunities for AI-powered data analytics, predictive modeling, and accelerated discovery services.

Probiotics Focus Specialization in a new class of antimicrobial probiotics positions GP as a potential partner for contract research, product development, and clinical testing in infectious diseases and microbiome-based therapeutics.

Funding & Growth Gap Current revenue is minimal and funding is modest, suggesting a strong need for strategic partnerships, grant-driven programs, and early-stage collaborations to scale capabilities and bring programs to milestones.

Sustainability Edge Probiotics-based antimicrobial approaches may offer lower environmental impact compared to traditional antimicrobials, presenting a differentiator for sustainability-focused customers and grant programs seeking green-health innovations.

Nearby Talent Pool Located in St. Paul with a small team, GP can benefit from regional partnerships with contract manufacturers, CROs, and universities to expand capabilities, accelerate timelines, and share development costs.